REQUEST A DEMO
Total
USD $0.00
Search more companies

Magnipharma SIA (Latvia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Magnipharma SIA Profile Updated: July 24, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Russian Download a sample report

Magnipharma SIA is a company based in Latvia, with its head office in Riga. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was first established on December 09, 2004. Magnipharma SIA currently employs 6 (2023) people. From the latest financial highlights, Magnipharma SIA reported a net sales revenue increase of 196.25% in 2025. During that time, Magnipharma SIA’s total assets grew by 129.03%. Magnipharma SIA’s net profit margin increased by 0.64% in 2025.

Headquarters
Meistaru iela 8 - 7
Riga; Riga; Postal Code: 1050

Contact Details: Purchase the Magnipharma SIA report to view the information.

Basic Information
Total Employees:
Purchase the Magnipharma SIA report to view the information.
Registered Capital:
Purchase the Magnipharma SIA report to view the information.
Financial Auditors:
Purchase the Magnipharma SIA report to view the information.
Incorporation Date:
December 09, 2004
Key Executives
Purchase this report to view the information.
Member of Management Board
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Magnipharma SIA report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
196.25%
Total Operating Revenue
196.25%
Operating Profit
804.05%
Net Profit/Loss for the Period
367%
Total Assets
129.03%
Total Equity
6.15%
Operating Profit Margin
2.02%
Net Profit Margin
0.64%
Return on Equity (ROE)
7.73%
Quick Ratio
-0.58%
Cash Ratio
-0.46%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?